Wilms Tumor 1 (WT1) (N-Term) Peptide
WT1
Reactivity: Human
Host: Synthetic
WB, BP
Catalog No. ABIN5511631
Quick Overview for Wilms Tumor 1 (WT1) (N-Term) Peptide (ABIN5511631)
Target
WT1
(Wilms Tumor 1 (WT1))
Origin
Human
Source
Synthetic
Application
Western Blotting (WB), Blocking Peptide (BP)
-
-
Protein Region
- N-Term
-
Sequence
- DFAPPGASAY GSLGGPAPPP APPPPPPPPP HSFIKQEPSW GGAEPHEEQC
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-WT1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- WT1 (Wilms Tumor 1 (WT1))
-
Background
-
WT1 is a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilm's tumors. Multiple transcript variants, resulting from alternative splicing at two coding exons, have been well characterized. There is also evidence for the use of non-AUG (CUG) translation initiation site upstream of, and in-frame with the first AUG, leading to additional isoforms.
Protein Size: 432 -
Gene ID
- 7490
Target
-
You are here:
